MT1‐MMP, but not secreted MMPs, influences the migration of human microvascular endothelial cells in 3‐dimensional collagen gels
暂无分享,去创建一个
Teruhiko Koike | E. Sadoun | M. Reed | T. Koike | May J Reed | R. Vernon | Robert B Vernon | Margaret A Hamner | Eman Sadoun | M. Hamner
[1] M. d’Ortho,et al. MT1‐MMP on the cell surface causes focal degradation of gelatin films , 1998, FEBS letters.
[2] A. Reiner,et al. Vascular endothelial growth factor increases release of gelatinase A and decreases release of tissue inhibitor of metalloproteinases by microvascular endothelial cells in vitro. , 1998, Microvascular research.
[3] C. Jackson,et al. Human microvascular endothelial cells differ from macrovascular endothelial cells in their expression of matrix metalloproteinases. , 1997, The international journal of biochemistry & cell biology.
[4] M. Cilli,et al. TIMP‐2, Over‐expression reduces invasion and angiogenesis and protects B16F10 melanoma cells from apoptosis. Int. J. Cancer 75, 246–253 (1998) , 1999, International journal of cancer.
[5] M. Reed,et al. A deficit in collagenase activity contributes to impaired migration of aged microvascular endothelial cells , 2000, Journal of cellular biochemistry.
[6] J. Jesty,et al. Vascular endothelial groth factor induces tissue factor and matrix metalloproteinase production in endothelial cells: Conversion of prothrombin to thrombin results in progelatininase a activation and cell proliferation , 1998, International journal of cancer.
[7] Donald E. Ingber,et al. How does extracellular matrix control capillary morphogenesis? , 1989, Cell.
[8] MS Pepper,et al. Extracellular Proteolysis and Angiogenesis , 2001, Thrombosis and Haemostasis.
[9] Juan P. Albar,et al. Membrane Type 1-Matrix Metalloproteinase Is Activated during Migration of Human Endothelial Cells and Modulates Endothelial Motility and Matrix Remodeling* , 2001, The Journal of Biological Chemistry.
[10] A. Mazar,et al. The role of the plasminogen activation system in angiogenesis and metastasis. , 2001, Surgical oncology clinics of North America.
[11] Gillian Murphy,et al. The TIMP2 Membrane Type 1 Metalloproteinase “Receptor” Regulates the Concentration and Efficient Activation of Progelatinase A , 1998, The Journal of Biological Chemistry.
[12] Y. Okada,et al. TIMP-2 Promotes Activation of Progelatinase A by Membrane-type 1 Matrix Metalloproteinase Immobilized on Agarose Beads* , 1998, The Journal of Biological Chemistry.
[13] K. Brew,et al. Residue 2 of TIMP-1 Is a Major Determinant of Affinity and Specificity for Matrix Metalloproteinases but Effects of Substitutions Do Not Correlate with Those of the Corresponding P1′ Residue of Substrate* , 1999, The Journal of Biological Chemistry.
[14] C. López-Otín,et al. Cellular Mechanisms for Human Procollagenase-3 (MMP-13) Activation , 1996, The Journal of Biological Chemistry.
[15] G. Murphy,et al. Membrane type 1 matrix metalloproteinase and gelatinase A synergistically degrade type 1 collagen in a cell model , 2001, FEBS letters.
[16] M. Bernardo,et al. Binding of Active (57 kDa) Membrane Type 1-Matrix Metalloproteinase (MT1-MMP) to Tissue Inhibitor of Metalloproteinase (TIMP)-2 Regulates MT1-MMP Processing and Pro-MMP-2 Activation* , 2000, The Journal of Biological Chemistry.
[17] R. Klebe,et al. Overview of matrix metalloproteinase expression in cultured human cells. , 1998, Matrix biology : journal of the International Society for Matrix Biology.
[18] W. Risau,et al. Mechanisms of angiogenesis , 1997, Nature.
[19] E. Bauer,et al. Vascular endothelial growth factor induces interstitial collagenase expression in human endothelial cells , 1992, Journal of cellular physiology.
[20] M. Cockett,et al. The C-terminal domain of 72 kDa gelatinase A is not required for catalysis, but is essential for membrane activation and modulates interactions with tissue inhibitors of metalloproteinases. , 1992, The Biochemical journal.
[21] M. Seiki,et al. Intermolecular Autolytic Cleavage Can Contribute to the Activation of Progelatinase A by Cell Membranes (*) , 1995, The Journal of Biological Chemistry.
[22] M. d’Ortho,et al. The activation of ProMMP-2 (gelatinase A) by HT1080 fibrosarcoma cells is promoted by culture on a fibronectin substrate and is concomitant with an increase in processing of MT1-MMP (MMP-14) to a 45 kDa form. , 1998, Journal of cell science.
[23] G. Butler,et al. The Soluble Catalytic Domain of Membrane Type 1 Matrix Metalloproteinase Cleaves the Propeptide of Progelatinase A and Initiates Autoproteolytic Activation , 1996, The Journal of Biological Chemistry.
[24] M. Cockett,et al. Different domain interactions are involved in the binding of tissue inhibitors of metalloproteinases to stromelysin-1 and gelatinase A. , 1994, Biochemistry.
[25] Y. Okada,et al. Membrane Type 1 Matrix Metalloproteinase Digests Interstitial Collagens and Other Extracellular Matrix Macromolecules* , 1997, The Journal of Biological Chemistry.
[26] W. Stetler-Stevenson,et al. Proteases in invasion: matrix metalloproteinases. , 2001, Seminars in cancer biology.
[27] S. Weiss,et al. Transmembrane-deletion Mutants of the Membrane-type Matrix Metalloproteinase-1 Process Progelatinase A and Express Intrinsic Matrix-degrading Activity (*) , 1996, The Journal of Biological Chemistry.
[28] P. Soloway,et al. TIMP-2 Is Required for Efficient Activation of proMMP-2 in Vivo * , 2000, The Journal of Biological Chemistry.
[29] A. Strongin,et al. Mechanism Of Cell Surface Activation Of 72-kDa Type IV Collagenase , 1995, The Journal of Biological Chemistry.
[30] K. Brew,et al. Tissue inhibitors of metalloproteinases: evolution, structure and function. , 2000, Biochimica et biophysica acta.
[31] R. Poorman,et al. Interstitial collagenase is required for angiogenesis in vitro. , 1994, Developmental biology.
[32] W. Stetler-Stevenson,et al. MMP-2: expression, activation and inhibition. , 1996, Enzyme & protein.
[33] M. Cilli,et al. TIMP‐2 over‐expression reduces invasion and angiogenesis and protects B16F10 melanoma cells from apoptosis , 1998 .
[34] T. Haas,et al. Three-dimensional Type I Collagen Lattices Induce Coordinate Expression of Matrix Metalloproteinases MT1-MMP and MMP-2 in Microvascular Endothelial Cells* , 1998, The Journal of Biological Chemistry.
[35] S. Maxwell,et al. Matrix metalloproteinase-1 and -9 activation by plasmin regulates a novel endothelial cell-mediated mechanism of collagen gel contraction and capillary tube regression in three-dimensional collagen matrices. , 2001, Journal of cell science.
[36] V. V. van Hinsbergh,et al. Regulation of matrix metalloproteinase expression in human vein and microvascular endothelial cells. Effects of tumour necrosis factor alpha, interleukin 1 and phorbol ester. , 1993, The Biochemical journal.
[37] U. K. Laemmli,et al. Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.
[38] E. Sage,et al. A novel, quantitative model for study of endothelial cell migration and sprout formation within three-dimensional collagen matrices. , 1999, Microvascular research.
[39] C. López-Otín,et al. Induction of matrix metalloproteinase activation cascades based on membrane-type 1 matrix metalloproteinase: associated activation of gelatinase A, gelatinase B and collagenase 3. , 1998, The Biochemical journal.
[40] Stephen J. Weiss,et al. Regulation of Cell Invasion and Morphogenesis in a Three-Dimensional Type I Collagen Matrix by Membrane-Type Matrix Metalloproteinases 1, 2, and 3 , 2000, The Journal of cell biology.
[41] Motoharu Seiki,et al. A matrix metalloproteinase expressed on the surface of invasive tumour cells , 1994, Nature.
[42] K. Brew,et al. Mutational Study of the Amino-terminal Domain of Human Tissue Inhibitor of Metalloproteinases 1 (TIMP-1) Locates an Inhibitory Region for Matrix Metalloproteinases* , 1997, The Journal of Biological Chemistry.
[43] M. Pepper. Role of the Matrix Metalloproteinase and Plasminogen Activator-Plasmin Systems in Angiogenesis , 2001, Arteriosclerosis, thrombosis, and vascular biology.